ArticleJournal of pharmacy & bioallied sciences2025
Human Exposure to Airborne Microplastics: A Study on Detection and Potential Health Effects Using BAL Fluid.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Airborne microplastics have emerged as a potential environmental health hazard, with increasing evidence of their presence in urban air. This study aimed to detect microplastic particles in human bronchoalveolar lavage (BAL) fluid and assess associated respiratory health impacts. Methods: A cross-sectional study was conducted on 60 adult patients undergoing diagnostic bronchoscopy. BAL fluid was collected and analyzed using polarized light microscopy and Fourier-transform infrared spectroscopy to identify microplastics. Inflammatory markers and pulmonary function tests were recorded and compared between individuals with and without detectable microplastics. Results: Microplastics were detected in 70% of BAL samples, with polyethylene (52.4%) and polypropylene (31.0%) being the most common polymers. Participants with microplastic exposure showed significantly lower mean FEV1 values (66.3%) compared to nonexposed individuals (82.7%). Inflammatory markers such as neutrophils and eosinophils were also elevated in the exposed group. A higher prevalence of respiratory symptoms was noted among those with detectable microplastics. Conclusion: The study highlights the presence of inhaled microplastics in the lower respiratory tract and their potential association with inflammation and impaired lung function. These findings emphasize the need for monitoring environmental exposure and assessing long-term health risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.